MARAVAI LIFESCIENCES HLDGS-A (MRVI)       14.415  -0.47 (-3.13%)

14.415  -0.47 (-3.13%)

US56600D1072 - Common Stock

MARAVAI LIFESCIENCES HLDGS-A14.415

NASDAQ:MRVI (12/1/2022, 10:28:04 AM)-0.47 (-3.13%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Life Sciences Tools & Services
Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend
Overview
Earnings (Last) 11-02 2022-11-02/amc Earnings (Next) 02-21 2023-02-21
Ins Owners 0.6% Inst Owners 98.98%
Market Cap 1.90B Shares 131.54M
PE 7.59 Fwd PE 16.31
Dividend Yield N/A Analysts 87.5
IPO 11-20 2020-11-20

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

MRVI Daily chart

Company Profile

Maravai Lifesciences Holdings, Inc. is a life sciences company. The company is headquartered in San Diego, California and currently employs 600 full-time employees. The company went IPO on 2020-11-20. The firm provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The firm's segments include Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. The company also provides research products for labeling and detecting proteins in cells and tissue samples. Its products include CleanCap, messenger ribonucleic acid (mRNA) and oligonucleotide. The Biologics Safety Testing focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing spectrum. The firm provides ultra-pure nucleotides to customers in the diagnostics, pharma, genomics and research markets.

Company Info

MARAVAI LIFESCIENCES HLDGS-A

10770 Wateridge Circle Suite 200, Suite 200

San Diego CALIFORNIA 92121

P: 18585460004.0

CEO: Carl Hull

Employees: 600

Website: https://www.maravai.com/

MRVI News

News Image3 days ago - The Motley Fool2 Biotech Stocks You Can Buy and Hold for the Next Decade

These two companies are facing short-term issues that are likely to give way to long-term success.

News Image15 days ago - Maravai LifeSciences Holdings LLCMaravai LifeSciences Named to the 2022 Deloitte Technology Fast 500™ List of Fastest-Growing Companies in North America

SAN DIEGO, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to...

News Image15 days ago - Maravai LifeSciences Holdings LLCMaravai LifeSciences Named to the 2022 Deloitte Technology Fast 500™ List of Fastest-Growing Companies in North AmericaNews Image24 days ago - Maravai LifeSciences Holdings LLCNew Kit Predicts Retroviral Particle Clearance in Biopharmaceutical Manufacturing

SOUTHPORT, N.C., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Cygnus Technologies, part of Maravai LifeSciences (Maravai) (NASDAQ: MRVI), the leading assay and...

News Image24 days ago - Maravai LifeSciences Holdings LLCNew Kit Predicts Retroviral Particle Clearance in Biopharmaceutical ManufacturingNews Imagea month ago - Maravai LifeSciences Holdings LLCMaravai LifeSciences Announces November and December 2022 Investor Conference Schedule

MRVI Twits

Here you can normally see the latest stock twits on MRVI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example